Precision Optics Corporation, Inc. (POCI)
USD 5.01
(0.2%)
USD 5.01
(0.2%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 8.52 Million USD | 1.78% |
| 2023 | 8.37 Million USD | 33.32% |
| 2022 | 6.27 Million USD | 44.73% |
| 2021 | 4.33 Million USD | -9.33% |
| 2020 | 4.78 Million USD | 83.57% |
| 2019 | 2.6 Million USD | 42.41% |
| 2018 | 1.83 Million USD | 2.98% |
| 2017 | 1.77 Million USD | -12.44% |
| 2016 | 2.03 Million USD | -0.4% |
| 2015 | 2.03 Million USD | 3.23% |
| 2014 | 1.97 Million USD | 4.39% |
| 2013 | 1.89 Million USD | 2.11% |
| 2012 | 1.85 Million USD | 6.21% |
| 2011 | 1.74 Million USD | 2.51% |
| 2010 | 1.7 Million USD | -20.43% |
| 2009 | 2.13 Million USD | -11.44% |
| 2008 | 2.41 Million USD | -29.2% |
| 2007 | 3.41 Million USD | 47.5% |
| 2006 | 2.31 Million USD | -22.95% |
| 2005 | 3 Million USD | -1.65% |
| 2004 | 3.05 Million USD | -7.89% |
| 2003 | 3.31 Million USD | -62.34% |
| 2002 | 8.79 Million USD | 65.37% |
| 2001 | 5.31 Million USD | 35.14% |
| 2000 | 3.93 Million USD | 35.72% |
| 1999 | 2.9 Million USD | -3.33% |
| 1998 | 3 Million USD | 11.11% |
| 1997 | 2.7 Million USD | 12.5% |
| 1996 | 2.4 Million USD | 14.29% |
| 1995 | 2.1 Million USD | 10.53% |
| 1994 | 1.9 Million USD | -36.67% |
| 1993 | 3 Million USD | 66.67% |
| 1992 | 1.8 Million USD | 125.0% |
| 1991 | 800 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.15 Million USD | 15.32% |
| 2024 Q4 | 2.38 Million USD | 12.45% |
| 2024 Q1 | 1.86 Million USD | -21.27% |
| 2024 Q3 | 2.11 Million USD | -1.76% |
| 2023 Q4 | 2.37 Million USD | 6.47% |
| 2023 Q3 | 2.22 Million USD | 9.91% |
| 2023 Q2 | 2.02 Million USD | 16.49% |
| 2023 Q1 | 1.74 Million USD | -6.98% |
| 2023 FY | 8.37 Million USD | 33.32% |
| 2022 Q4 | 1.87 Million USD | 4.61% |
| 2022 FY | 6.27 Million USD | 44.73% |
| 2022 Q1 | 1.03 Million USD | -15.16% |
| 2022 Q2 | 1.57 Million USD | 52.09% |
| 2022 Q3 | 1.78 Million USD | 13.25% |
| 2021 Q2 | 1.06 Million USD | 9.61% |
| 2021 Q4 | 1.22 Million USD | 14.0% |
| 2021 FY | 4.33 Million USD | -9.33% |
| 2021 Q1 | 973.57 Thousand USD | 0.0% |
| 2021 Q3 | 1.07 Million USD | 0.64% |
| 2020 Q3 | 1.28 Million USD | -12.73% |
| 2020 Q1 | 1.05 Million USD | 27.99% |
| 2020 FY | 4.78 Million USD | 83.57% |
| 2020 Q4 | 973.55 Thousand USD | -24.09% |
| 2020 Q2 | 1.46 Million USD | 38.64% |
| 2019 Q1 | 761.28 Thousand USD | 40.85% |
| 2019 Q2 | 481.32 Thousand USD | -36.77% |
| 2019 Q4 | 828.17 Thousand USD | 54.48% |
| 2019 FY | 2.6 Million USD | 42.41% |
| 2019 Q3 | 536.11 Thousand USD | 11.38% |
| 2018 Q4 | 540.48 Thousand USD | 4.95% |
| 2018 FY | 1.83 Million USD | 2.98% |
| 2018 Q1 | 415.01 Thousand USD | -0.12% |
| 2018 Q2 | 360.06 Thousand USD | -13.24% |
| 2018 Q3 | 514.97 Thousand USD | 43.02% |
| 2017 Q3 | 440.89 Thousand USD | -4.51% |
| 2017 FY | 1.77 Million USD | -12.44% |
| 2017 Q1 | 460.77 Thousand USD | -2.68% |
| 2017 Q2 | 461.7 Thousand USD | 0.2% |
| 2017 Q4 | 415.53 Thousand USD | -5.75% |
| 2016 FY | 2.03 Million USD | -0.4% |
| 2016 Q3 | 525.69 Thousand USD | 2.03% |
| 2016 Q2 | 515.23 Thousand USD | -0.11% |
| 2016 Q1 | 515.79 Thousand USD | -10.79% |
| 2016 Q4 | 473.44 Thousand USD | -9.94% |
| 2015 Q3 | 550.72 Thousand USD | 13.4% |
| 2015 FY | 2.03 Million USD | 3.23% |
| 2015 Q2 | 485.66 Thousand USD | 14.58% |
| 2015 Q1 | 423.85 Thousand USD | -9.51% |
| 2015 Q4 | 578.15 Thousand USD | 4.98% |
| 2014 Q1 | 470.95 Thousand USD | 2.84% |
| 2014 Q3 | 576.17 Thousand USD | 25.52% |
| 2014 FY | 1.97 Million USD | 4.39% |
| 2014 Q2 | 459.01 Thousand USD | -2.54% |
| 2014 Q4 | 468.4 Thousand USD | -18.71% |
| 2013 Q1 | 488.25 Thousand USD | -5.29% |
| 2013 Q4 | 457.95 Thousand USD | -10.14% |
| 2013 Q2 | 435.57 Thousand USD | -10.79% |
| 2013 Q3 | 509.65 Thousand USD | 17.01% |
| 2013 FY | 1.89 Million USD | 2.11% |
| 2012 FY | 1.85 Million USD | 6.21% |
| 2012 Q3 | 508.52 Thousand USD | 20.0% |
| 2012 Q2 | 423.76 Thousand USD | 4.75% |
| 2012 Q1 | 404.54 Thousand USD | -3.28% |
| 2012 Q4 | 515.53 Thousand USD | 1.38% |
| 2011 FY | 1.74 Million USD | 2.51% |
| 2011 Q1 | 495.21 Thousand USD | 6.92% |
| 2011 Q2 | 426.75 Thousand USD | -13.82% |
| 2011 Q3 | 421.72 Thousand USD | -1.18% |
| 2011 Q4 | 418.27 Thousand USD | -0.82% |
| 2010 Q4 | 463.15 Thousand USD | 6.81% |
| 2010 Q2 | 478.15 Thousand USD | 46.46% |
| 2010 Q3 | 433.6 Thousand USD | -9.32% |
| 2010 Q1 | 326.46 Thousand USD | -43.13% |
| 2010 FY | 1.7 Million USD | -20.43% |
| 2009 Q1 | 548.55 Thousand USD | -1.13% |
| 2009 FY | 2.13 Million USD | -11.44% |
| 2009 Q2 | 527.05 Thousand USD | -3.92% |
| 2009 Q3 | 488.61 Thousand USD | -7.29% |
| 2009 Q4 | 574.08 Thousand USD | 17.49% |
| 2008 FY | 2.41 Million USD | -29.2% |
| 2008 Q2 | 786.47 Thousand USD | 1.1% |
| 2008 Q1 | 777.94 Thousand USD | -6.62% |
| 2008 Q4 | 554.83 Thousand USD | 87.99% |
| 2008 Q3 | 295.13 Thousand USD | -62.47% |
| 2007 Q3 | 904.63 Thousand USD | -2.2% |
| 2007 FY | 3.41 Million USD | 47.5% |
| 2007 Q4 | 833.07 Thousand USD | -7.91% |
| 2007 Q2 | 924.94 Thousand USD | 33.74% |
| 2007 Q1 | 691.61 Thousand USD | 6.8% |
| 2006 Q2 | 684.73 Thousand USD | 46.59% |
| 2006 Q1 | 467.09 Thousand USD | -32.99% |
| 2006 FY | 2.31 Million USD | -22.95% |
| 2006 Q4 | 647.57 Thousand USD | 26.34% |
| 2006 Q3 | 512.55 Thousand USD | -25.15% |
| 2005 Q2 | 659.79 Thousand USD | -22.73% |
| 2005 Q4 | 697.07 Thousand USD | -11.77% |
| 2005 Q3 | 790.02 Thousand USD | 19.74% |
| 2005 Q1 | 853.84 Thousand USD | 13.84% |
| 2005 FY | 3 Million USD | -1.65% |
| 2004 Q1 | 696.4 Thousand USD | -29.61% |
| 2004 Q4 | 750.04 Thousand USD | -8.1% |
| 2004 Q3 | 816.18 Thousand USD | 3.52% |
| 2004 Q2 | 788.43 Thousand USD | 13.22% |
| 2004 FY | 3.05 Million USD | -7.89% |
| 2003 Q1 | 812.28 Thousand USD | -84.9% |
| 2003 Q4 | 989.35 Thousand USD | 33.6% |
| 2003 Q3 | 740.51 Thousand USD | -3.86% |
| 2003 Q2 | 770.22 Thousand USD | -5.18% |
| 2003 FY | 3.31 Million USD | -62.34% |
| 2002 FY | 8.79 Million USD | 65.37% |
| 2002 Q2 | 1.21 Million USD | -75.62% |
| 2002 Q1 | 4.98 Million USD | 425.11% |
| 2002 Q3 | 1.05 Million USD | -13.14% |
| 2002 Q4 | 5.37 Million USD | 409.1% |
| 2001 Q1 | 1.18 Million USD | 16.6% |
| 2001 FY | 5.31 Million USD | 35.14% |
| 2001 Q3 | 1.73 Million USD | 19.98% |
| 2001 Q4 | 950.12 Thousand USD | -45.34% |
| 2001 Q2 | 1.44 Million USD | 22.64% |
| 2000 FY | 3.93 Million USD | 35.72% |
| 2000 Q4 | 1.01 Million USD | -2.85% |
| 2000 Q3 | 1.04 Million USD | 4.29% |
| 2000 Q2 | 1 Million USD | 11.11% |
| 2000 Q1 | 900 Thousand USD | 50.0% |
| 1999 FY | 2.9 Million USD | -3.33% |
| 1999 Q1 | 700 Thousand USD | -12.5% |
| 1999 Q2 | 800 Thousand USD | 14.29% |
| 1999 Q3 | 800 Thousand USD | 0.0% |
| 1999 Q4 | 600 Thousand USD | -25.0% |
| 1998 FY | 3 Million USD | 11.11% |
| 1998 Q4 | 800 Thousand USD | 14.29% |
| 1998 Q1 | 700 Thousand USD | -12.5% |
| 1998 Q2 | 800 Thousand USD | 14.29% |
| 1998 Q3 | 700 Thousand USD | -12.5% |
| 1997 Q3 | 600 Thousand USD | 0.0% |
| 1997 Q1 | 700 Thousand USD | -12.5% |
| 1997 Q4 | 800 Thousand USD | 33.33% |
| 1997 FY | 2.7 Million USD | 12.5% |
| 1997 Q2 | 600 Thousand USD | -14.29% |
| 1996 FY | 2.4 Million USD | 14.29% |
| 1996 Q2 | 700 Thousand USD | 16.67% |
| 1996 Q1 | 600 Thousand USD | -14.29% |
| 1996 Q4 | 800 Thousand USD | 33.33% |
| 1996 Q3 | 600 Thousand USD | -14.29% |
| 1995 Q4 | 700 Thousand USD | 16.67% |
| 1995 Q2 | 600 Thousand USD | 50.0% |
| 1995 Q1 | 400 Thousand USD | -20.0% |
| 1995 FY | 2.1 Million USD | 10.53% |
| 1995 Q3 | 600 Thousand USD | 0.0% |
| 1994 Q3 | 400 Thousand USD | 0.0% |
| 1994 Q1 | 500 Thousand USD | -54.55% |
| 1994 Q2 | 400 Thousand USD | -20.0% |
| 1994 FY | 1.9 Million USD | -36.67% |
| 1994 Q4 | 500 Thousand USD | 25.0% |
| 1993 Q1 | 500 Thousand USD | 108.47% |
| 1993 Q4 | 1.1 Million USD | 83.33% |
| 1993 Q3 | 600 Thousand USD | -14.29% |
| 1993 FY | 3 Million USD | 66.67% |
| 1993 Q2 | 700 Thousand USD | 40.0% |
| 1992 FY | 1.8 Million USD | 125.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 100.0% |
| 1992 Q4 | -5.9 Million USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | -4.2 Million USD | 0.0% |
| 1991 FY | 800 Thousand USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 91.827% |
| AngioDynamics, Inc. | 252.41 Million USD | 96.624% |
| AtriCure, Inc. | 327.05 Million USD | 97.394% |
| Avinger, Inc. | 18.63 Million USD | 54.276% |
| Azenta, Inc. | 336.26 Million USD | 97.466% |
| BioLife Solutions, Inc. | 117.57 Million USD | 92.752% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 99.533% |
| Daxor Corporation | 1.28 Million USD | -565.522% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 64.772% |
| Femasys Inc. | 15.2 Million USD | 43.935% |
| GlucoTrack, Inc. | 7.1 Million USD | -19.962% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 85.452% |
| Hologic, Inc. | 1.34 Billion USD | 99.366% |
| ICU Medical, Inc. | 717.04 Million USD | 98.812% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.712% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 67.358% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 90.566% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 7241.692% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 7241.692% |
| Masimo Corporation | 867 Million USD | 99.017% |
| Microbot Medical Inc. | 9.85 Million USD | 13.525% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 53.735% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 98.147% |
| Nephros, Inc. | 9.78 Million USD | 12.897% |
| NovoCure Limited | 613.92 Million USD | 98.612% |
| NEXGEL, Inc. | 4.09 Million USD | -108.059% |
| NEXGEL, Inc. | 4.09 Million USD | -108.059% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 91.665% |
| OraSure Technologies, Inc. | 125.34 Million USD | 93.201% |
| Pro-Dex, Inc. | 7.37 Million USD | -15.507% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 80.442% |
| Predictive Oncology Inc. | 15.22 Million USD | 44.042% |
| QuidelOrtho Corporation | 1.35 Billion USD | 99.371% |
| Repligen Corporation | 261.12 Million USD | 96.736% |
| Sanara MedTech Inc. | 61.12 Million USD | 86.058% |
| STAAR Surgical Company | 224.55 Million USD | 96.205% |
| Sharps Technology, Inc. | 10.12 Million USD | 15.845% |
| Utah Medical Products, Inc. | 13.26 Million USD | 35.736% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.525% |
| Jin Medical International Ltd. | 3.91 Million USD | -117.536% |